Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,984 | -2,768 | -2,775 | -2,852 | -1,134 |
| Depreciation Amortization | 72 | 94 | 73 | 62 | 50 |
| Accounts receivable | -24 | -36 | 21 | -202 | -23 |
| Accounts payable and accrued liabilities | -76 | -466 | 562 | 7 | 70 |
| Other Working Capital | 493 | 147 | 517 | -44 | 107 |
| Other Operating Activity | 265 | 617 | -512 | 320 | 217 |
| Operating Cash Flow | $-1,253 | $-2,414 | $-2,113 | $-2,709 | $-712 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | -374 | -47 | -106 | -36 |
| Investing Cash Flow | $-28 | $-374 | $-47 | $-106 | $-36 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,145 | 2,825 | 2,200 | 2,750 | N/A |
| Common Stock Issued | N/A | N/A | 2 | N/A | 879 |
| Other Financing Activity | 0 | 3 | 0 | 2 | -198 |
| Financing Cash Flow | $1,145 | $2,828 | $2,202 | $2,752 | $681 |
| Beginning Cash Position | 139 | 99 | 57 | 119 | 185 |
| End Cash Position | 3 | 139 | 99 | 57 | 119 |
| Net Cash Flow | $-136 | $40 | $42 | $-62 | $-66 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,253 | -2,414 | -2,113 | -2,709 | -712 |
| Capital Expenditure | -28 | -374 | -47 | -106 | -36 |
| Free Cash Flow | -1,281 | -2,787 | -2,160 | -2,815 | -748 |